Ventricular tachycardia triggered by the first dose of an adenoviral vector‐based COVID‐19 vaccine in an adult patient with congenital heart disease
Author(s) -
Bassareo Pier Paolo,
Mihali Klevis,
Walsh Kevin Patrick
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6064
Subject(s) - medicine , covid-19 , adverse effect , heart disease , cardiology , disease , viral vector , virology , infectious disease (medical specialty) , recombinant dna , biochemistry , chemistry , gene
A unique adverse event of adenoviral COVID‐19 vaccine in an adult patient with congenital heart disease is reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom